OLR1 and acute coronary syndrome: sLOX-1 is elevated in the systemic and coronary circulation of patients with acute coronary syndrome (ACS) [25, 26] and is proposed as a marker for presence of active and vulnerable inflammatory atherosclerotic lesions [47].